Abstract:Objective The investigation aimed at producing transgenic mouse model with myocardium-specific overex-pression of human KCNE4 (hKCNE4) gene so as to research into the prophylactic and therapeutic effect of hKCNE4 gene on a certain subset of atrial fibrillation. Methods hKCNE 4 gene was cloned by reverse transcription-polymerase chain reaction (RT-PCR), digested with restrictive endonuclease, and inserted into the cardiomyocyte-specific expressing plasmidα-MHC-Clone 26 by ligase. Enzymatic and sequencing analyses were performed to confirm hKCNE4-α-MHC-Clone 26 prior to obtaining the BamHI treated transgenic element hKCNE4-α-MHC-hGH pA. The hKCNE4-α-MHC-hGH pA was microinjected into the male pronucleus of fertilized oocyte of C57BL mice and the oocytes surviving microin-jection were transplanted into the oviducts of pseudo-pregnant mice. The positive transgenic founder (G0 generation) mice were identified by PCR from offspring generated by pseudo-pregnant mice. The G0 transgenic mice were mated respectively with wild-type C57BL mice to reproduce G1 transgenic progeny. RT-PCR and sequencing were applied to screening for transgenic mice expressing hKCNE4 from G1 transgenic descendants. Results hKCNE4 gene was cloned and ligated to the vectorα-MHC-Clone 26 correctly. 86 mice were generated 9 of which were identified to be transgenic and the trans-gene hKCNE 4 carried by 2 transgenic mice (titled as Line A and Line B respectively) was not only transmitted to the next generation but also overexpressed restrictedly in the hearts. Preliminary phenotypic analysis on the transgenic progeny of Line A and Line B showed that they developed normally, reproduced generally, and suffered from no arrhythmia documented by surface electrocardiography. Conclusion The results indicate that the transgenic mice cardiomyocyte-specifically overexpressing hKCNE 4 are successfully procured, which provides a valuable tool for the exploration of the preventive and remedial influence of hKCNE 4 on a subgroup of atrial fibrillation.

Establishment and Identification of Cramp Transgenic Mice

Establishment of Hamster- and Human-Prnp Transgenic Mice.

Influence of Cramp over Expression on the Function of Hematopoietic Stem Cell

Establishment and Phenotype Analysis of Cardiac-specific Creg Gene Conditional Knockout Mice

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Functional Assessment of Expression of Cre Recombinase Targeting the Liver of Transgenic Mice Regulated by Tet-on and Cre/loxP System

Construction and Tissue Specific Expression of Cre Transgenic Mice

Influence of Cramp Knockout on Cell Development of Spleen and Thymus in Mice

Establishment of adipocytokine CTRP4 transgenic mouse

Establishment of two cardiac-specific human cardiac troponin C mutation transgenic mice and comparative analysis

Influence of Cramp Knockout on the Function of Hematopoietic Stem Cell

Biological Characteristics and Transgenic Study of Rat Cardiac Fibroblasts Culture in Vitro

Establishment of a human APOA1 transgenic mouse model

Establishment of Transgenic Mice Carrying Gene Encoding Human Zinc Finger Protein 191

Production of a Mouse Line with a Conditional Crim1 Mutant Allele

Generation of Transgenic Mice for Cardiovascular Research.

Establishment of transgenic mice which express SARS coronavirus functional receptor human ACE2

Establishment of Mouse Model Highly Expressing Bcl-2 Protein

Establishment of transgenic mouse models expressing human HSP22 protein

Animal Model for Heterologous Transplantation-Generating of Transgenic Mice That Expresses Hcd59 Cdna

[The Establishment of Conditional MT Transgenic Mice Model].